Icahn School of Medicine at Mount Sinai · GeneticsMorava-Kozicz Neurodevelopment Lab
Eva Morava-Kozicz · New York, New York
Research Focus
Dr. Eva Morava-Kozicz leads a research lab focused on understanding how congenital disorders of glycosylation (CDG) affect brain development and function. By using various model systems, such as zebrafish and human brain organoids, her team investigates the molecular mechanisms that lead to neurological symptoms like seizures and intellectual disabilities in CDG patients. The goal is to uncover how defects in glycosylation pathways impact neural cells and potentially identify new therapeutic targets.
Congenital Disorders of Glycosylationglycosylationneural functionneurodevelopmentzebrafishDrosophilahuman organoidsneurological diseasecell type modeling
Research Aims
3AIM 01Investigate the specific cell types that drive neurological phenotypes in CDG.
AIM 02Define molecular mechanisms responsible for disease-associated neurological symptoms.
AIM 03Identify genetic modifiers that influence CDG disease pathogenesis.
Skills the Lab Values
Zebrafish modelsDrosophila experimentshuman cortical organoidscell cultureproteomicsgenetic analysisneurophysiologymodel organism techniquesglycoproteomics
Output against the department
Publications27bottom 3% of dept.250th of 259
this lab
most publishedleast published
Citations691bottom 2% of dept.253rd of 259
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.